SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-267198
Filing Date
2023-10-31
Accepted
2023-10-31 16:05:30
Documents
14
Period of Report
2023-10-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d577074d8k.htm   iXBRL 8-K 25861
2 EX-99.1 d577074dex991.htm EX-99.1 9233
6 GRAPHIC g577074g1031053139678.jpg GRAPHIC 12005
  Complete submission text file 0001193125-23-267198.txt   184043

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amrn-20231031.xsd EX-101.SCH 2518
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20231031_lab.xml EX-101.LAB 19293
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20231031_pre.xml EX-101.PRE 12081
8 EXTRACTED XBRL INSTANCE DOCUMENT d577074d8k_htm.xml XML 4167
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21392 | Film No.: 231364552
SIC: 2834 Pharmaceutical Preparations